TipRanks on MSN
RAPT Therapeutics Reports Positive Phase 2 Trial Results
RAPT Therapeutics ( ($RAPT) ) just unveiled an update. On October 20, 2025, RAPT Therapeutics and Shanghai Jeyou Pharmaceutical Co., Ltd.
Arquitos Capital shares its Q3 2025 investor letter highlighting a 66.8% YTD return and value-driven strategy. Read how ...
Philip Morris International Inc. is now rated Hold due to lower P/E, inventory changes, and smoke-free product updates. Learn ...
A local attorney had a front row seat to arguments before the Supreme Court in Delaware involving a record pay deal for Elon Musk. Naples attorney Tom Grady sat in the courtroom on Oct. 15, along with ...
ET Now on MSN
Power Stock To BUY On Diwali Muhurat Trading 2025: Expert predicts 21% return in 1 year - Check target price
The stock under discussion is a BSE 200 power generation company, which has a current market price of Rs 525.30 on BSE. The ...
Two gods, in the theatre of Greek myth, embody the eternal struggle between order and chaos. Apollo is the guardian of ...
PointZero Group, a Dh120 billion ($33 billion) entity, is formed through a merger of three Abu Dhabi companies, focusing on ...
This Delta-8 THC tincture essentially serves as the bitters of the cannabis world. Just add a few drops to your favorite ...
Rani Therapeutics stock surged 200% after securing a $1 billion partnership with Chugai and raising $60 million in funding.
It’s not the first time the celebrated horror author has retained veto rights on casting for film adaptations of his ...
Zacks spotlights five efficient stocks Red Robin, 10x Genomics, Norwegian Cruise Line, Electromed, and Analog Devices that ...
After a full week of pulling back, AUD /JPY has found a footing at previous support and a lower trendline. The confluence, which marked a higher low following a higher high, is a signal that this pair ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results